Código QR (código de barras bidimensional)

Assessment of fragile histidine triad (FHIT) gene expression as a predictive biomarker of therapeutic response in chronic myeloid leukemia

BACKGROUND: The accumulation of other abnormalities in both genetic and epigenetic pathways, in addition to the BCR-ABL1 oncoprotein, affects the overall clinical consequences of chronic myeloid leukemia (CML), including treatment responsiveness. OBJECTIVES: This study investigated the expression le...

ver descrição completa

Na minha lista:
Principais autores: Noor Hashim Ismail, Amal Mohamed Ali, Asmaa Amer Almukhtar
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Medknow Publications 2026-01-01
coleção:Iraqi Journal of Hematology
Assuntos:
chronic myeloid leukemia
fragile histidine triad gene expression
imatinib mesylate
treatment response
Acesso em linha:https://journals.lww.com/10.4103/ijh.ijh_140_25
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados